1. Kim, Jung, Gianferante, Matthew, Karyadi, Danielle M, Stewart, Douglas R, Mirabello, Lisa. 2021. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in the Childhood Cancer Survivor Study. In JNCI cancer spectrum, 5, . doi:10.1093/jncics/pkab007. https://pubmed.ncbi.nlm.nih.gov/34308104/
2. Liang, Xuqin, He, Qing, Jiao, Yuhua, Huang, Huimei, Zhao, Huaxiang. 2024. Identification of rare variants in PTCH2 associated with non-syndromic orofacial clefts. In Gene, 907, 148280. doi:10.1016/j.gene.2024.148280. https://pubmed.ncbi.nlm.nih.gov/38360123/
3. Wang, Xiaotong, Ma, Zhihong, Wu, Yan, Fan, Ming, Du, Juan. 2021. Expression pattern of Ptch2 in mouse embryonic maxillofacial development. In Acta histochemica, 124, 151835. doi:10.1016/j.acthis.2021.151835. https://pubmed.ncbi.nlm.nih.gov/34979374/
4. Han, Jizhong, Deng, Huajiang, Xiong, Yu, Peng, Lilei, Zhong, Chuanhong. 2022. Reduced PTCH2 expression is associated with glioma development through its regulation of the PTEN/AKT signaling pathway. In Biochemical and biophysical research communications, 627, 76-83. doi:10.1016/j.bbrc.2022.08.043. https://pubmed.ncbi.nlm.nih.gov/36027694/
5. Smyth, I, Narang, M A, Evans, T, Wicking, C, Wainwright, B J. . Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. In Human molecular genetics, 8, 291-7. doi:. https://pubmed.ncbi.nlm.nih.gov/9931336/